NCT03297684View on ClinicalTrials.gov

Assessment of Biomarker Profile in Diabetic Macular Edema With Intravitreal Aflibercept Injection

UnknownOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

April 11, 2018

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Diabetic Macular Edema
Interventions
DRUG

Aflibercept Injection [Eylea]

Intravitreal injection aflibercept

Trial Locations (1)

02747

Advanced Eye Centers, South Dartmouth

Sponsors
All Listed Sponsors
lead

Advanced Eye Research Associates

INDUSTRY

NCT03297684 - Assessment of Biomarker Profile in Diabetic Macular Edema With Intravitreal Aflibercept Injection | Biotech Hunter | Biotech Hunter